BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 15935889)

  • 1. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of acceptable HLA mismatches in immunized patients using single-antigen-expressing cell lines.
    Eijsink C; Zoet YM; Kardol MJ; Witvliet MD; Claas FH; Mulder A; Doxiadis II
    Tissue Antigens; 2007 Apr; 69(4):354-7. PubMed ID: 17389021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.
    Kosmoliaptsis V; Bradley JA; Peacock S; Chaudhry AN; Taylor CJ
    Transplantation; 2009 Mar; 87(6):813-20. PubMed ID: 19300182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
    D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
    Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
    Han M; Rogers JA; Lavingia B; Stastny P
    Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes.
    Poláková K; Kuba D; Russ G
    Hum Immunol; 2004 Feb; 65(2):157-62. PubMed ID: 14969770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation.
    Mulder A; Kardol MJ; Arn JS; Eijsink C; Franke ME; Schreuder GM; Haasnoot GW; Doxiadis II; Sachs DH; Smith DM; Claas FH
    Mol Immunol; 2010 Jan; 47(4):809-15. PubMed ID: 19931911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera.
    Ravindranath MH; Kaneku H; El-Awar N; Morales-Buenrostro LE; Terasaki PI
    J Immunol; 2010 Aug; 185(3):1935-48. PubMed ID: 20610644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer.
    Bernabeu C; Finlay D; van de Rijn M; Maziarz RT; Biro PA; Spits H; de Vries J; Terhorst CP
    J Immunol; 1983 Oct; 131(4):2032-7. PubMed ID: 6352810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.